|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of Pittsburgh |
|---|---|
| Information provided by: | University of Pittsburgh |
| ClinicalTrials.gov Identifier: | NCT00471757 |
Purpose
The proposed study aims to provide current information, etiology and outcome of community-acquired pneumonia (CAP), risk factors for for CAP in isolates of Streptococcus pneumoniae and Haemophilus influencae, Mycoplasma pneumoniae, chlamydia pneumoniae and Legionella. Risk factors, including patient demographics, comorbid illnesses, setting of presentation, causative organisms, antibiotic history, and resistance profiles will be assessed and outcome will be recorded.
| Condition |
|---|
|
Streptococcus Pneumonia Haemophilus Influencae Mycoplasma Pneumonia Chlamydial Pneumonia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
| Official Title: | Etiology of Community Acquired Pneumonia |
| Estimated Enrollment: | 200 |
| Study Start Date: | May 2007 |
| Estimated Study Completion Date: | December 2013 |
The following information will be collected: age, sex, occupation, hospital location at the time of positive culture (ER, medical ward, ICU etc), date of positive culture, prior hospitalization, receipt of outpatient dialysis, home care or other regular medical care (eg, outpatient chemotherapy), presence of invasive devices, receipt of antibiotics, including their type and whether they were adequate for the resistance profile of the organism, prior positive microbiologic cultures, time and location of positive cultures, underlying diseases and severity of illness, co-morbid illnesses, presence of urinary or intravascular devices, recent immunomodulative therapies or radiation therapy, physical exam findings, laboratory and radiographical data, antimicrobial usage within 30 days of onset of the infection, microbiological data and resistance patterns, choice of antibiotics once organism identified, bacteriological outcomes, laboratory results, demographic information, medications, clinical outcome,gender, height, weight, ethnicity, and past medical history. We will collect information retrospectively.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
streptococcus pneumoniae positive
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: David L Paterson, MD | 412-648-6401 | patersond@dom.pitt.edu |
| Contact: Diana Lynn Pakstis, RN, BSN | 412-648-6553 | pakstisdl@dom.pitt.edu |
| United States, Pennsylvania | |
| University of Pittsburgh Medical Center | Recruiting |
| Pittsburgh, Pennsylvania, United States, 15213 | |
| Contact: David L Paterson, MD 412-648-6401 patersond@dom.pitt.edu | |
| Contact: Diana Lynn Pakstis, RN, BSN 412-648-6553 pakstisdl@dom.pitt.edu | |
| Principal Investigator: David L Paterson, MD | |
| Sub-Investigator: Megan Terrebonne | |
| Principal Investigator: | David L Paterson, MD | University of Pittsburgh/University of Pittsburgh Medical Center |
More Information
| Responsible Party: | David Paterson, MD, UPMC |
| ClinicalTrials.gov Identifier: | NCT00471757 History of Changes |
| Other Study ID Numbers: | PRO07040291 |
| Study First Received: | May 9, 2007 |
| Last Updated: | February 18, 2011 |
| Health Authority: | United States: Institutional Review Board |
|
pnuemonia influenca |
|
Pleuropneumonia Mycoplasma Infections Pneumonia, Mycoplasma Psittacosis Pneumonia Lung Diseases Respiratory Tract Diseases Pleurisy |
Pleural Diseases Respiratory Tract Infections Mycoplasmatales Infections Gram-Negative Bacterial Infections Bacterial Infections Pneumonia, Bacterial Chlamydophila Infections Chlamydiaceae Infections |